IVD Market in China 2017-2021

IVD Market in China 2017-2021

About In-vitro diagnostics (IVD)

IVD procedures are conducted outside of a living organism in a test tube, petri dish, or culture dish. Whereas, in vivo diagnostics are carried out inside a living organism. IVD products are intended to collect biological samples such as blood, sputum, urine, spinal fluid, and DNA from a patient's body. They are analyzed in hospitals, clinics, and laboratories. IVD products are reagents and instruments that help in the diagnosis of diseases.

Technavio’s analysts forecast the in-vitro diagnostics (IVD) market in China to grow at a CAGR of 14.39% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of in-vitro diagnostics (IVD) market in China for 2017-2021. To calculate the market size, the report considers the new installations/shipments/sales/volume/value.Technavio's report, In-vitro diagnostics (IVD) Market in China 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

• Roche Diagnostics
• Abbott
• Siemens Healthineers

Other prominent vendors

• Atlas Link Biotech
• Autobio Diagnostics
• Bioneovan
• Bioptik Technology
• Bio-Rad Laboratories
• Boson Biotech
• C&G Biotech
• Cepheid
• Changchun Wancheng Bio-elect
• Changsha City Epower Electronics & Science
• Chongqing Haray International Business
• Cusabio Biotech
• Dako
• Fudakang Ind'l
• GE Healthcare
• Grifols
• Maya Medical Equipment Limited
• Hologic
• Illumina
• Innovation Biotech
• Intec Products
• Jiangxi Zhongchenda Industrial Investment
• Jiaxing Smir Medical Devices
• Johnson & Johnson
• Luminex
• Nantong Egens Biotechnology
• Nantong Voyage International Trade
• PerkinElmer
• Qiagen
• Quest Diagnostics
• Quicking Biotech
• Secure Detect
• Shanghai Jiuyi International Trade
• Shanghai Kehua Bio-Engineering
• Shanghai Outdo Biotech
• Shenzhen Fitconn Technology
• Shiny Health Import & Export
• Shenzhen New Industries Biomedical Engineering
• Sunrising Enterprise
• Wuhan HNC Technology
• Yuan Yu Bio-Tech
• Zhejiang Orient Gene Biotech

Market driver

• Increase in incidences of chronic and infectious diseases
• For a full, detailed list, view our report

Market challenge

• Increase in demand and expectations of improved healthcare facilities
• For a full, detailed list, view our report

Market trend

• Companion diagnostics
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Press Release

Technavio Announces the Publication of its Research Report – In-vitro diagnostics (IVD) Market in China 2017-2021

Technavio recognizes the following companies as the key players in the in-vitro diagnostics (IVD) market in China: Roche Diagnostics, Abbott, and Siemens Healthineers.

Other Prominent Vendors in the market are: Atlas Link Biotech, Autobio Diagnostics, Bioneovan, Bioptik Technology, Bio-Rad Laboratories, Boson Biotech, C&G Biotech, Cepheid, Changchun Wancheng Bio-elect, Changsha City Epower Electronics & Science, Chongqing Haray International Business, Cusabio Biotech, Dako, Fudakang Ind'l, GE Healthcare, Grifols, Maya Medical Equipment Limited, Hologic, Illumina, Innovation Biotech, Intec Products, Jiangxi Zhongchenda Industrial Investment, Jiaxing Smir Medical Devices, Johnson & Johnson, Luminex, Nantong Egens Biotechnology, Nantong Voyage International Trade, PerkinElmer, Qiagen, Quest Diagnostics, Quicking Biotech, Secure Detect, Shanghai Jiuyi International Trade, Shanghai Kehua Bio-Engineering, Shanghai Outdo Biotech, Shenzhen Fitconn Technology, Shiny Health Import & Export, Shenzhen New Industries Biomedical Engineering, Sunrising Enterprise, Wuhan HNC Technology, Yuan Yu Bio-Tech, and Zhejiang Orient Gene Biotech.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is companion diagnostics. Companion diagnostics or simply CDx are the tests done to ensure safe and effective use of a corresponding drug or a biological product. It helps a healthcare professional to measure a therapeutic product's applicability on a specific individual. These tests are developed along with the manufacturing of the related drugs. Its application detects whether an individual is a right candidate for the particular therapy or not. These tests can be mainly seen in the oncology field where drugs are too expensive.”

According to the report, one of the major drivers for this market is increase in incidences of chronic and infectious diseases. There is a steep rise in incidences of chronic and infectious diseases that have become a major concern for the Chinese government as well as a major driver for the growth of the IVD market in China. The demand for various diagnostic tests such as glucose monitoring, cardiac biomarkers, and cholesterol testing is increasing due to the growing prevalence of diabetes and obesity.

Further, the report states that one of the major factors hindering the growth of this market is increase in demand and expectations of improved healthcare facilities. Over the past decade, the demand for IVD tests has increased, as more number of individuals are opting for diagnostics tests. The increased health consciousness and rise in middle-class population with more spending power have increased the demand for best-quality care. With the rise in urbanization, people are expecting wider and quicker access to the diagnostic tests to avail right treatment at the right time. However, the rising burden of the population makes it more tough for the Chinese government, as there are inadequate healthcare facilities to meet the growing diagnostics demand of China.

Companies Mentioned

Roche Diagnostics, Abbott, Siemens Healthineers, Atlas Link Biotech, Autobio Diagnostics, Bioneovan, Bioptik Technology, Bio-Rad Laboratories, Boson Biotech, C&G Biotech, Cepheid, Changchun Wancheng Bio-elect, Changsha City Epower Electronics & Science, Chongqing Haray International Business, Cusabio Biotech, Dako, Fudakang Ind'l, GE Healthcare, Grifols, Maya Medical Equipment Limited, Hologic, Illumina, Innovation Biotech, Intec Products, Jiangxi Zhongchenda Industrial Investment, Jiaxing Smir Medical Devices, Johnson & Johnson, Luminex, Nantong Egens Biotechnology, Nantong Voyage International Trade, PerkinElmer, Qiagen, Quest Diagnostics, Quicking Biotech, Secure Detect, Shanghai Jiuyi International Trade, Shanghai Kehua Bio-Engineering, Shanghai Outdo Biotech, Shenzhen Fitconn Technology, Shiny Health Import & Export, Shenzhen New Industries Biomedical Engineering, Sunrising Enterprise, Wuhan HNC Technology, Yuan Yu Bio-Tech, and Zhejiang Orient Gene Biotech.